Human bone marrow-derived mesenchymal cell reactions to 316L stainless steel: An in vitro study on cell viability and interleukin-6 expression

8Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Purpose: Human bone marrow-derived mesenchymal cell (hBMC) reactions to 316L stainless steel (316L-SS) have never been evaluated. The objective of this study was to assess cell viability and interleukin-6 expression of hBMC cultures upon treatment with a 316L-SS implant. Methods: A cytotoxicity analysis was conducted with a 3-(4,5-dimethylthiazol 2-yl)-2,5- diphenyltetrazolium (MTT) assay after a period of 24, 48 and 72 hours of incubation. Expression of interleukin-6 was measured using enzyme-linked immunosorbent assay (ELISA). Results: Cell viability measurement was performed via IC50 formula. All treatment group showed a > 50 % cell viability with a range of 56,5 - 96,9 % at 24 hours, 51,8-77,3% at 48 hours and 70,1- 120 % at 72 hours. Interleukin-6 expression was downregulated subsequent to treatment with 316L-SS compared to the control group. Conclusion: We found that 316L-SS did not exhibit toxicity towards hBMC culture.

Cite

CITATION STYLE

APA

Anwar, I. B., Santoso, A., Saputra, E., Ismail, R., Jamari, J., & van der Heide, E. (2017). Human bone marrow-derived mesenchymal cell reactions to 316L stainless steel: An in vitro study on cell viability and interleukin-6 expression. Advanced Pharmaceutical Bulletin, 7(2), 335–338. https://doi.org/10.15171/apb.2017.040

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free